DE1018342T1 - Diagnose und Behandlung bakterieller Dysenterie - Google Patents

Diagnose und Behandlung bakterieller Dysenterie

Info

Publication number
DE1018342T1
DE1018342T1 DE1018342T DE00101263T DE1018342T1 DE 1018342 T1 DE1018342 T1 DE 1018342T1 DE 1018342 T DE1018342 T DE 1018342T DE 00101263 T DE00101263 T DE 00101263T DE 1018342 T1 DE1018342 T1 DE 1018342T1
Authority
DE
Germany
Prior art keywords
gal
beta
treatment
slt
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1018342T
Other languages
English (en)
Other versions
DE10001263C2 (de
DE10001263A1 (de
Inventor
Glen D Armstrong
R Murray Ratcliffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synsorb Biotech Inc
Original Assignee
Synsorb Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synsorb Biotech Inc filed Critical Synsorb Biotech Inc
Publication of DE1018342T1 publication Critical patent/DE1018342T1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DE1018342T 1991-10-18 1992-10-19 Diagnose und Behandlung bakterieller Dysenterie Pending DE1018342T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77873291A 1991-10-18 1991-10-18

Publications (1)

Publication Number Publication Date
DE1018342T1 true DE1018342T1 (de) 2001-01-11

Family

ID=25114261

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69231675T Expired - Fee Related DE69231675T2 (de) 1991-10-18 1992-10-19 Behandlung bakterieller dysenterie
DE1018342T Pending DE1018342T1 (de) 1991-10-18 1992-10-19 Diagnose und Behandlung bakterieller Dysenterie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69231675T Expired - Fee Related DE69231675T2 (de) 1991-10-18 1992-10-19 Behandlung bakterieller dysenterie

Country Status (9)

Country Link
US (3) US5620858A (de)
EP (2) EP1018342A3 (de)
AT (1) ATE198991T1 (de)
CA (1) CA2121604C (de)
DE (2) DE69231675T2 (de)
DK (1) DK0610356T3 (de)
ES (2) ES2150888T1 (de)
GR (1) GR3035665T3 (de)
WO (1) WO1993008209A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231675T2 (de) * 1991-10-18 2001-06-28 Synsorb Biotech Inc Behandlung bakterieller dysenterie
US5484773A (en) * 1994-02-14 1996-01-16 Alberta Research Council Treatment of antibiotic associated diarrhea
US5627163A (en) * 1995-06-05 1997-05-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5637576A (en) * 1995-06-05 1997-06-10 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5661131A (en) * 1995-06-05 1997-08-26 Synsorb Biotech, Inc. Treatment of cholera
US5811409A (en) * 1995-06-05 1998-09-22 Synsorb Biotech, Inc. Treatment of cholera
US5891860A (en) * 1996-03-11 1999-04-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US6069137A (en) * 1996-03-11 2000-05-30 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
CN1209752A (zh) * 1996-06-21 1999-03-03 辛索尔布生物技术有限公司 用于中和大肠杆菌毒素的寡糖的用途
JPH107575A (ja) * 1996-06-21 1998-01-13 Synsorb Biotec Inc 細菌性赤痢の処置
US6013634A (en) * 1996-11-08 2000-01-11 Synsorb Biotech, Inc. Solid support matrices containing a toxin binding oligosaccharide
US5846943A (en) * 1996-11-08 1998-12-08 Synsorb Biotech, Inc. Solid support matricles containing a toxin binding oligosaccharide
US5910579A (en) * 1997-01-10 1999-06-08 Synsorb Biotech Inc. Processes for the preparation of αGal(1->4)βGal (1->4) Glc-OR
US5888750A (en) * 1997-05-30 1999-03-30 Synsorb Biotech, Inc. Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
ZA991410B (en) * 1998-02-23 1999-10-06 Synsorb Biotech Inc Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
WO1999053320A1 (en) 1998-04-15 1999-10-21 Utah State University Real time detection of antigens
US7220596B2 (en) * 1998-04-15 2007-05-22 Utah State University Real time detection of antigens
US5962423A (en) * 1998-08-07 1999-10-05 The Governors Of The University Of Alberta Treatment of bacterial dysentery
US6310043B1 (en) 1998-08-07 2001-10-30 Governors Of The University Of Alberta Treatment of bacterial infections
US7135173B2 (en) * 2000-07-13 2006-11-14 Idaho Research Foundation, Inc. Antiviral activity of Shiga toxin
US6541013B1 (en) 2000-07-13 2003-04-01 Idaho Research Foundation, Inc. Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide
US20060051440A1 (en) * 2002-09-10 2006-03-09 Joel Moss Factors that bind intestinal toxins
BE1019290A5 (nl) 2010-04-14 2012-05-08 Nutrition Sciences Nv Sa Voedingsupplement omvattende oligosachariden en middellange keten vetzuren.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56500138A (de) * 1979-03-16 1981-02-12
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0058665B1 (de) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrat-derivate zum hemmen eines bakteriellen anhaftens
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
US4946943A (en) * 1985-06-20 1990-08-07 Will Bloch Purification of ribotoxins and their conjugates
US4863852A (en) * 1985-07-03 1989-09-05 Virginia Tech Intellectual Properties, Inc. Method of detecting, isolating and purifying clostridium difficile toxin A and its receptors
US5164298A (en) * 1988-06-24 1992-11-17 Hsc Research Development Corporation Verocytotoxin receptor assay
US5168063A (en) * 1990-07-27 1992-12-01 Wisconsin Alumni Research Foundation Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11
DE69231675T2 (de) * 1991-10-18 2001-06-28 Synsorb Biotech Inc Behandlung bakterieller dysenterie
AU667533B2 (en) * 1992-03-26 1996-03-28 Microcarb, Inc. Monospecific polyclonal antibodies to shiga-like toxins
US5484773A (en) * 1994-02-14 1996-01-16 Alberta Research Council Treatment of antibiotic associated diarrhea

Also Published As

Publication number Publication date
DE69231675D1 (de) 2001-03-08
ES2150888T1 (es) 2000-12-16
CA2121604C (en) 2002-01-15
GR3035665T3 (en) 2001-06-29
DE69231675T2 (de) 2001-06-28
ATE198991T1 (de) 2001-02-15
DK0610356T3 (da) 2001-02-19
EP1018342A3 (de) 2001-04-11
EP1018342A2 (de) 2000-07-12
US5955449A (en) 1999-09-21
CA2121604A1 (en) 1993-04-29
ES2154265T3 (es) 2001-04-01
EP0610356B1 (de) 2001-01-31
WO1993008209A1 (en) 1993-04-29
US5679653A (en) 1997-10-21
US5620858A (en) 1997-04-15
EP0610356A1 (de) 1994-08-17
EP0610356A4 (de) 1995-03-29

Similar Documents

Publication Publication Date Title
DE1018342T1 (de) Diagnose und Behandlung bakterieller Dysenterie
AU698275B2 (en) Treatment of antibiotic associated diarrhea
Heerze et al. Oligosaccharide sequences attached to an inert support (SYNSORB) as potential therapy for antibiotic-associated diarrhea and pseudomembranous colitis
US6107282A (en) Treatment of C. difficile toxin B associated conditions
CA2460749A1 (en) Glycoconjugate vaccines for use in immune-compromised populations
GR3020984T3 (en) Use of rifaximin and pharmaceutical compositions containing it in the treatment of gastric dyspepsia caused by helicobacter pylori.
AU3042995A (en) Diagnostic testing for campylobacter jejuni or coli infection using antigens
PT1017404E (pt) Formulacao farmaceutica para o tratamento de doenca inflamatoria do intestino
Ertl et al. Nocardial endocarditis of an aortic valve prosthesis.
US6291435B1 (en) Treatment of diarrhea caused by enteropathogenic Escherichia coli
NZ302632A (en) Treatment of traveller's diarrhea using a pharmaceutical composition containing a saccharide sequence
US6358930B1 (en) Treatment of C. difficile toxin B associated conditions
Gaut et al. Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections
KR20010032128A (ko) 항생제 및 독소결합성 올리고사카라이드 조성물을사용하여 세균성 이질을 치료하는 화합물 및 방법
Lähdevirta Ciprofloxacin in the elimination of enteric Salmonella carriage stage
Chidiac et al. Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens
Geddes et al. Co-trimoxazole for the treatment of serious infections
NZ332434A (en) Use of oligosaccharide compositions which bind one or more serotypes of cholerae toxin in the intestinal tract for the treatment of cholera and related conditions
WO1997049431A3 (en) Use of oligosaccharides for neutralising e. coli toxins
Vincent et al. Experience with Tobramygin and Cephalothin Sodium in Infected Patients with Acute Leukaemia (AL)
Edwards et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response
Abrahm Management of the immunocompromised host
Hattori A Report on a Patient with Abdominal Colic Well Treated with Toki-shigyaku-ka-goshuyu-shokyo-to A Report on a Patient Suspected of “Senki” Syndrome Type A
Mayfield et al. Ward environment and the severely regressed patient.
Zelinsky The enzymatic incorporation of paratose residues into O-specific polysaccharides of Salmonella.